Advanced Biomed (ADVB) Income from Continuing Operations (2023 - 2026)
Advanced Biomed (ADVB) posted Income from Continuing Operations of 488942.0 for Q1 2026, down 106.98% sequentially from 7002178.0 in Q4 2025, and up 59.17% YoY from 307182.77 in Q1 2025.
Advanced Biomed (ADVB) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Advanced Biomed has reported Income from Continuing Operations for 4 years, with the latest figure at 488942.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 59.17% year-over-year to 488942.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4629472.0 (up 262.33% YoY) and the FY2025 annual result came in at 3258969.0, down 17.13% from the prior year.
- Income from Continuing Operations eased to 488942.0 in Q1 2026 per ADVB's latest filing, from 7002178.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 7002178.0 in Q4 2025 and troughed at 1496863.0 in Q2 2025.
- A 4-year average of 57593.7 and a median of 534218.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations plunged 298.7% in 2024, then soared 1308.33% in 2025.
- Over 4 years, Income from Continuing Operations stood at 145345.0 in 2023, then tumbled by 298.7% to 579494.0 in 2024, then jumped by 1308.33% to 7002178.0 in 2025, then tumbled by 106.98% to 488942.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 488942.0, 7002178.0, and 386901.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Advanced Biomed | 12.28 Mn | 12.28 Mn | - | -488,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -488,942.00 |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | -386,901.00 |
| Jun 30, 2025 | -1.50 Mn |
| Mar 31, 2025 | -1.20 Mn |
| Dec 31, 2024 | -579,494.00 |
| Sep 30, 2024 | -265,580.00 |
| Jun 30, 2024 | -809,386.00 |
| Mar 31, 2024 | -1.06 Mn |
| Dec 31, 2023 | -145,345.00 |